Date: September 25 - 26, 2019
Add to your calendar
Contact: Thomas Hoffmann
2019 ISPE Europe Biotechnology Conference - Visit Allegheny Bradford Corporation in Table 15.
Biopharmaceuticals have become a main pillar in the pharmaceutical industry, with significant transformation in the development, strategy, technology and operations. This transformation is a continuous process, which is impacted by other developments in digitalization amongst other factors.
Entirely new concepts, such as gene - and cell therapy, are being brought to market, which offers even more possibilities to regenerative medicine or disease remission. However, there are still operational and technological challenges.
Reproducing large molecules reliably at an industrial scale requires manufacturing capabilities of a previously unknown complexity and sophistication. The starting material that produces recombinant therapeutics are genetically modified living cells that must be frozen for storage, thawed without damage, and made to grow in a reaction vessel. The molecules must then be separated from the cells that cultivated them and the media in which they were produced, all without destroying their complex, fragile structures. This process requires new technologies and capabilities and will be explored at our conference.
Go Back | Send this page to a friend